Postpartum Hemorrhage: Clinical Trials

15 trials for Postpartum Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 terminated, 3 unknown, 1 not yet recruiting. 15 Phase 1, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 115Completed 7, Terminated 3, Unknown 3, Not yet recruiting 1, Withdrawn 1
Phase 27Completed 3, Unknown 2, Terminated 1, Withdrawn 1

Follow Postpartum Hemorrhage: new trials by email Literature Review of Postpartum Hemorrhage trials Research Report on Postpartum Hemorrhage

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS
Tranexamic Acid (TXA), Placebo - Post Partum Hemorrhage
Phase 1Not yet recruitingPatel Hospital, Pakistan1042025-06-012025-06-04
Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women
Carbetocin 100 Microgram/mL Solution for Injection - Obesity, Maternal, Post Partum Hemorrhage
Phase 1 / Phase 2CompletedCairo University1502023-07-062024-01-22
A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects
Carbetocin, Placebo, Placebo and Moxifloxacin - Postpartum Hemorrhage
Phase 1CompletedFerring Pharmaceuticals402023-05-252024-09-03
Comparative Study Between the Roles of Intrauterine Misoprostol Versus the Sublingual Route for Prevention of Postpartum Blood Loss in Elective Cesarean Sections
Misoprostol - Postpartum Hemorrhage
Phase 1CompletedCairo University1922022-01-012024-04-15
A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)
fibrinogen concentrate, Placebo - Postpartum Hemorrhage
Phase 1 / Phase 2WithdrawnYale University2021-01-012021-03-15
Tranexamic Acid for the Prevention of Postpartum Haemorrhage
Tranexamic Acid 100 milligram/Milliliter, Oxytocin - Postpartum Hemorrhage
Phase 1 / Phase 2UnknownBenha University602020-01-012021-01-13
Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility
Oxytocin - Post Partum Haemorrhage
Phase 1TerminatedOxytone Bioscience BV42018-04-032019-11-22
Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women
IH Oxytocin, IM Oxytocin, IV Oxytocin - Postpartum Hemorrhage
Phase 1TerminatedGlaxoSmithKline312016-11-232020-03-23
Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH
Tranexamic Acid and Ethamsylate - Postpartum Hemorrhage
Phase 1 / Phase 2UnknownAhmed Alanwar642015-11-012015-11-30
Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers
IM oxytocin 10 IU, IH oxytocin 50 mcg, IH oxytocin 200 mcg - Postpartum Hemorrhage
Phase 1CompletedGlaxoSmithKline162015-09-142017-10-19
Tampostat for Management of Postpartum Hemorrhage
Tampostat, Condom catheter tamponade - Postpartum Hemorrhage
Phase 1 / Phase 2TerminatedInternational Centre for Diarrhoeal Disease Research, Bangladesh3442015-04-012018-11-26
Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor
oxytocin, saline - Postpartum Hemorrhage
Phase 1UnknownAin Shams University12015-01-012016-03-02
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
Misoprostol, Oxytocin - Post Partum Hemorrhage
Phase 1CompletedHormozgan University of Medical Sciences4002013-05-012015-03-26
Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section
Misoprostol, Oxytocin, Oxytocin and Misoprostol - Post Partum Haemorrhage
Phase 1 / Phase 2CompletedQazvin University Of Medical Sciences1502012-02-012012-10-11
Evaluation of Melatonin's Effect on Pain and Blood Loss After Cesarean Section
melatonin 3mg, melatonin 6mg, placebo - Post Partum Haemorrhage in Patients Undergoing Cesarean Section
Phase 1 / Phase 2CompletedQazvin University Of Medical Sciences1202012-02-012012-10-11

Narrower conditions

Pain (1)  ·  Pregnancy in Obesity (1)  ·  Thrombosis (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (15)  ·  Hemorrhage (15)  ·  Obstetric Labor Complications (15)  ·  Pathologic Processes (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Pregnancy Complications (15)  ·  Puerperal Disorders (15)  ·  Urogenital Diseases (15)  ·  Uterine Hemorrhage (15)  ·  Signs and Symptoms (2)  ·  Body Weight (1)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Neurologic Manifestations (1)  ·  Nutrition Disorders (1)

Interventions

Oxytocin (6)  ·  Misoprostol (3)  ·  Sodium Chloride (2)  ·  Tranexamic Acid (2)  ·  Control Groups (1)  ·  Ethamsylate (1)  ·  Fibrinogen (1)  ·  Injections (1)  ·  Melatonin (1)  ·  Moxifloxacin (1)  ·  carbetocin (1)

Sponsors

Cairo University (2)  ·  GlaxoSmithKline (2)  ·  Qazvin University Of Medical Sciences (2)  ·  Ahmed Alanwar (1)  ·  Ain Shams University (1)  ·  Benha University (1)  ·  Ferring Pharmaceuticals (1)  ·  Hormozgan University of Medical Sciences (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Oxytone Bioscience BV (1)  ·  Patel Hospital, Pakistan (1)  ·  Yale University (1)

Countries

Egypt (4)  ·  Iran (3)  ·  United Kingdom (2)  ·  Australia (1)  ·  Bangladesh (1)  ·  Pakistan (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Abubaker M Elnashar, MD (1)  ·  Aminur Rahman, MBBS,MSc (1)  ·  Michael J Paidas, MD (1)  ·  Minoo Rajaei, Dr (1)  ·  Zohreh Shahboodaghi, Dr (1)

Results publications

PMID 10467792, PMID 10908457, PMID 11502292, PMID 14600674, PMID 15954876, PMID 16581405, PMID 16842791, PMID 17197859, PMID 17634155, PMID 19432563, PMID 19943825, PMID 20009308, PMID 22540529, PMID 22882240, PMID 24734184, PMID 28781129, PMID 31598047, PMID 32609374, PMID 37485589, PMID 37522415, PMID 39472831, PMID 42802704

NIH funding

2016 (1)